Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tourmaline Bio, Inc., A Novartis Company

Clinical trials sponsored by Tourmaline Bio, Inc., A Novartis Company, explained in plain language.

Now part of Novartis AG NVS NYSE

A biotech company, now part of Novartis, developing immunotherapies for autoimmune diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New injection every 8 weeks shows promise for thyroid eye disease

Disease control Ongoing

This study tests a drug called TOUR006 in 79 people with active thyroid eye disease, a condition that causes eye bulging and inflammation. Participants receive either a low dose, high dose, or placebo injection every 8 weeks. The main goal is to see if the drug can reduce eye bul…

Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc., a Novartis Company • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC